Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of EGFR CART Cells for Patients With Metastatic Colorectal Cancer.

NCT03152435 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.

NCT NCT03152435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03152435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of EGFR CART Cells for Patients With Metastatic Colorectal Cancer.
Lead sponsor
Shenzhen Second People's Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 15, 2017
Completion date
December 31, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr-positive colorectal cancer